MORF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.767600E-01
Normal-vs-Stage2
6.200800E-01
Normal-vs-Stage3
5.795000E-01
Normal-vs-Stage4
8.746600E-01
Stage1-vs-Stage2
8.179200E-01
Stage1-vs-Stage3
9.921400E-01
Stage1-vs-Stage4
4.820800E-01
Stage2-vs-Stage3
5.173400E-01
Stage2-vs-Stage4
2.866800E-01
Stage3-vs-Stage4
4.433600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.230600E-01
Normal-vs-AfricanAmerican
7.981400E-01
Normal-vs-Asian
5.052600E-01
Caucasian-vs-AfricanAmerican
2.474400E-01
Caucasian-vs-Asian
3.020000E-01
AfricanAmerican-vs-Asian
7.964000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.107200E-01
Normal-vs-Female
6.459400E-01
Male-vs-Female
5.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.931800E-01
Normal-vs-Age(41-60Yrs)
7.823200E-01
Normal-vs-Age(61-80Yrs)
5.729800E-01
Normal-vs-Age(81-100Yrs)
2.799600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.278100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.459160E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.079800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.982300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.353390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.848400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.947000E-01
Normal-vs-Daily Drinker
4.829000E-01
Normal-vs-Weekly Drinker
6.297000E-01
Normal-vs-Occasional Drinker
5.811200E-01
Normal-vs-Social Drinker
3.290800E-01
Non Drinker-vs-Daily Drinker
8.516400E-01
Non Drinker-vs-Weekly Drinker
1.649380E-01
Non Drinker-vs-Occasional Drinker
5.976400E-02
Non Drinker-vs-Social Drinker
4.281600E-01
Daily Drinker-vs-Weekly Drinker
1.383230E-01
Daily Drinker-vs-Occasional Drinker
4.940100E-02
Daily Drinker-vs-Social Drinker
3.727200E-01
Weekly Drinker-vs-Occasional Drinker
4.737200E-01
Weekly Drinker-vs-Social Drinker
8.165800E-01
Occasional Drinker-vs-Social Drinker
3.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
3.083600E-01
Grade 1-vs-Grade 3
1.796390E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
6.037200E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.977400E-01
Normal-vs-NonDiabetic
5.671000E-01
Diabetic-vs-NonDiabetic
6.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.135000E-01
Normal-vs-NoPancreatitis
5.951800E-01
Pancreatitis-vs-NoPancreatitis
2.193200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.438400E-01
Normal-vs-N1
6.285000E-01
N0-vs-N1
8.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.072000E-01
Normal-vs-TP53-NonMutant
5.379600E-01
TP53-Mutant-vs-TP53-NonMutant
7.503700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
